James B. Couch, M.D., J.D., director-in-charge of disease management for Coopers & Lybrand Integrated Healthcare Consulting, has published his second book, "The Physician's Guide to Disease Management." However, the comprehensive guide to disease management's initiatives, strategies and trends is not intended only for physicians. Representatives may read it to strengthen their understanding of this popular trend in managed health care.
James B. Couch, M.D., J.D., director-in-charge of disease management for Coopers & Lybrand Integrated Healthcare Consulting, has published his second book, "The Physician's Guide to Disease Management." However, the comprehensive guide to disease management's initiatives, strategies and trends is not intended only for physicians. Representatives may read it to strengthen their understanding of this popular trend in managed health care.
Pharmaceutical Representative: Why is a guide to disease management needed today?
Couch: There are so many misconceptions about what disease or health management is. Every group that has tried to define disease management in one way or another has had a different spin on it. Consequently, we need a book that can tie all the different perspectives together. We need to establish a common framework for what disease management is, as well as what it isn't.
Pharmaceutical Representative: Which diseases are the targets of the different programs?
Couch: Diabetes is one of the diseases and the book discusses how those patients were managed. Prenatal care, asthma and hypertension are also covered.
Pharmaceutical Representative: How can a pharmaceutical representative use your book?
Couch: The entire book is useful for salespeople who are in the business of calling on physicians to help them prescribe the best medicines.
One chapter specifically covers disease management in pharmaceutical companies. Others focus on evidence-based medicine, outcomes-validated clinical practice guidelines and examples of successfully implemented disease management programs.
These chapters would be relevant and interesting to a pharmaceutical representative. PR
The Transformative Role of Medical Information in Customer Engagement
October 3rd 2024Stacey Fung, Head of Global Medical Information at Gilead Lifesciences, delves into the evolving role of Medical Information (MI) in the pharmaceutical industry. Covering key topics like patient engagement through omnichannel strategies, combating misinformation, and leveraging AI to enhance medical inquiries, the conversation with Stacey highlights MI's critical role in ensuring patient safety and supporting drug development. She also shares her professional journey and tidbits for early career professionals on professional development.
Unlocking value and cost savings in patient services with technology and talent
October 2nd 2024Traci Miller, Director, Sonexus™ Access and Patient Support, Cardinal Health, discusses the current digital trends in the patient services industry and how the optimal balance of technology and talent can transform manufacturer-sponsored patient support programs. Hear how Cardinal Health combines best-in-class program and pharmacy operations with smart digital tools to ensure product and patient success and reduce operational costs.